Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Illinois at Chicago
- Study ID
- NCT00490464
- Status
- Completed
Conditions
- Intracerebral Hemorrhage
- Subarachnoid Hemorrhage
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Nicardipine and Nipride — DRUG
Study Details
The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any procedures performed are experimental.
Key Dates
- Start date
- Jun 30, 2004
- Status verified
- Jun 2007
- Completion
- Feb 28, 2007
Study Design
- Enrollment
- 163 participants (actual)
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Illinois at Chicago, UIC | Chicago | Illinois | 60612 | - |
Find similar trials in Chicago, IL
By research site
Related Studies
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverYRecruiting · Massachusetts General Hospital · Phoenix, Arizona
- ROSE-Longitudinal Assessment With NeuroimagingRecruiting · State University of New York at Buffalo · Chicago, Illinois
- Hemodynamic ABI MonitorRecruiting · University of Chicago · Chicago, Illinois